REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
15/12/2025
Voltar para busca
Dado oficial do USPTO
CELLINK X
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
16/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
27/12/2017
Data de registro
15/12/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/12/2020
Última transação
16/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Göteborg, SE
Examinador
BUTTON,JENNIFER JO
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cellink AB
CELLINK BIOPRINTING AB
Representantes
Margarita Wallach McCarter & English, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biologically compatible polymershydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medicalscientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrayshuman and animal organconnectiveepithelialmuscularnervous tissues and tissue arraysfor use in scientific and medical research; Biologically compatible materialshydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research
Classe 5
Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organshuman and animal cardiovascularpulmonarydigestivehepatobiliaryurologicalrenalendocrineconnectiveepithelialmuscularnervous tissue and organsfor medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of boneblood and tissue for medical purposes; Pharmaceutical products for tissue regenerationfor tissue repairfor tissue treatmentwhether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseasesfor cartilaginous diseasesfor vascular diseasesfor neuronal degenerationfor degeneration of tendons and ligamentsfor retinal degenerationfor renal degenerationdegeneration of soft tissuefor diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy productsgenetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Natural biomaterials for augmentation of bone and tissue for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
15/12/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
09/11/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/11/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/10/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
08/10/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/07/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/07/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/07/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/05/2020
PUBO
PUBLISHED FOR OPPOSITION
19/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/04/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
14/03/2020
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
08/07/2019
GECD
ACTION DENYING REQ FOR RECON E-MAILED
08/07/2019
CNCF
ACTION CONTINUING FINAL - COMPLETED
08/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2019
EXPI
EX PARTE APPEAL-INSTITUTED
29/05/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
29/05/2019
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
29/05/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/05/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/11/2018
GNFR
FINAL REFUSAL E-MAILED
28/11/2018
CNFR
FINAL REFUSAL WRITTEN
28/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/10/2018
ALIE
ASSIGNED TO LIE
18/10/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/10/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/04/2018
GNRT
NON-FINAL ACTION E-MAILED
09/04/2018
CNRT
NON-FINAL ACTION WRITTEN
09/04/2018
DOCK
ASSIGNED TO EXAMINER
06/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2018
NWAP
NEW APPLICATION ENTERED
30/12/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLINK X ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.